Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIA V MALLIA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1902648942
CMS profile
11600510
Location
VERO BEACH, FL

General Payments · PY2024

$790.77

  • Reported across 16 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$790.77

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $790.77 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $286.88 5
ATRICURE, INC. $170.00 1
Edwards Lifesciences Corporation $139.73 1
Novo Nordisk AS $35.17 2
EISAI INC. $32.65 1
Otsuka America Pharmaceutical, Inc. $27.34 1
SHIELD THERAPEUTICS INC $24.82 1
Exact Sciences Corporation $22.11 1
Amgen Inc. $18.96 1
TOLMAR, INC. $16.78 1
Lilly USA, LLC $16.33 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $790.77 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $18.96 08/06/2024 Food and Beverage Undisputed 01/23/2026 1117618440 CMS
AstraZeneca Pharmaceuticals LP $25.90 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105506040 CMS
AstraZeneca Pharmaceuticals LP $125.00 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104454956 CMS
AstraZeneca Pharmaceuticals LP $9.73 09/25/2024 Food and Beverage Undisputed 01/23/2026 1104448899 CMS
AstraZeneca Pharmaceuticals LP $99.99 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105725425 CMS
AstraZeneca Pharmaceuticals LP $26.26 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104627226 CMS
ATRICURE, INC. $170.00 10/21/2024 Food and Beverage Undisputed 01/23/2026 1132838625 CMS
Edwards Lifesciences Corporation $139.73 09/19/2024 Food and Beverage Undisputed 01/23/2026 1138848303 CMS
Eisai Inc. $32.65 08/13/2024 Food and Beverage Undisputed 01/23/2026 1110813276 CMS
Exact Sciences Corporation $22.11 12/17/2024 Food and Beverage Undisputed 01/23/2026 1114563307 CMS
Lilly USA, LLC $16.33 07/23/2024 Food and Beverage Undisputed 01/23/2026 1135806228 CMS
Novo Nordisk Inc $15.89 07/25/2024 Food and Beverage Undisputed 01/23/2026 1100329124 CMS
Novo Nordisk Inc $19.28 09/11/2024 Food and Beverage Undisputed 01/23/2026 1100572628 CMS
Otsuka America Pharmaceutical, Inc. $27.34 09/24/2024 Food and Beverage Undisputed 01/23/2026 1119128632 CMS
SHIELD THERAPEUTICS INC $24.82 09/17/2024 Food and Beverage Undisputed 01/23/2026 1150146258 CMS
Tolmar, Inc. $16.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 1138717732 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.